Renaissance Technologies (RenTech)'s IART Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 14,760 shares of Integra LifeSciences Holdings Corporation (IART) worth $183,319, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in IART, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 303,000 shares. Largest reduction occurred in Q2 2018, reducing 235,340 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Integra LifeSciences Holdings Corporation (IART) Holding Value Over Time
Track share changes against reported price movement
Quarterly Integra LifeSciences Holdings Corporation (IART) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,760 | New Buy | 14,760 | $12.42 |
| Q1 2024 | -103,560 | Sold Out | 0 | $0.00 |
| Q4 2023 | +103,560 | New Buy | 103,560 | $43.55 |
| Q3 2023 | -66,300 | Sold Out | 0 | $0.00 |
| Q2 2023 | -98,191 | Reduce 59.69% | 66,300 | $0.04 |
| Q1 2023 | +41,291 | Add 33.52% | 164,491 | $0.06 |
| Q4 2022 | -207,573 | Reduce 62.75% | 123,200 | $0.06 |
| Q3 2022 | +159,913 | Add 93.59% | 330,773 | $42.36 |
| Q2 2022 | +10,400 | Add 6.48% | 170,860 | $54.03 |
| Q1 2022 | +120,600 | Add 302.56% | 160,460 | $64.26 |
| Q4 2021 | +30,600 | Add 330.45% | 39,860 | $66.98 |
| Q3 2021 | -47,800 | Reduce 83.77% | 9,260 | $68.47 |
| Q2 2021 | +57,060 | New Buy | 57,060 | $68.24 |
| Q4 2020 | -30,660 | Sold Out | 0 | $0.00 |
| Q3 2020 | +30,660 | New Buy | 30,660 | $47.23 |
| Q2 2020 | -93,060 | Sold Out | 0 | $0.00 |
| Q1 2020 | -77,700 | Reduce 45.50% | 93,060 | $44.67 |
| Q4 2019 | -102,300 | Reduce 37.46% | 170,760 | $58.28 |
| Q3 2019 | +180,300 | Add 194.37% | 273,060 | $60.07 |
| Q2 2019 | +92,760 | New Buy | 92,760 | $55.85 |
| Q1 2019 | -148,360 | Sold Out | 0 | $0.00 |
| Q4 2018 | -209,800 | Reduce 58.58% | 148,360 | $45.10 |
| Q3 2018 | +303,000 | Add 549.31% | 358,160 | $65.87 |
| Q2 2018 | -235,340 | Reduce 81.01% | 55,160 | $64.41 |
| Q1 2018 | -115,300 | Reduce 28.41% | 290,500 | $55.34 |
| Q4 2017 | +194,900 | Add 92.41% | 405,800 | $47.86 |
| Q3 2017 | +201,200 | Add 2074.23% | 210,900 | $50.48 |
| Q2 2017 | -163,960 | Reduce 94.41% | 9,700 | $54.54 |
| Q1 2017 | +173,660 | New Buy | 173,660 | $42.13 |
| Q4 2016 | -38,060 | Sold Out | 0 | $0.00 |
| Q3 2016 | -167,000 | Reduce 81.44% | 38,060 | $41.28 |
| Q2 2016 | +138,400 | Add 207.62% | 205,060 | $39.89 |
| Q1 2016 | -36,000 | Reduce 35.07% | 66,660 | $33.68 |
| Q4 2015 | -7,200 | Reduce 6.55% | 102,660 | $33.89 |
| Q3 2015 | +73,624 | Add 203.18% | 109,860 | $29.77 |
| Q2 2015 | -92,424 | Reduce 71.84% | 36,236 | $33.70 |
| Q1 2015 | +117,860 | Add 1091.30% | 128,660 | $30.83 |
| Q4 2014 | +10,800 | New Buy | 10,800 | $27.13 |
| Q3 2014 | -15,060 | Sold Out | 0 | $0.00 |
| Q2 2014 | +15,060 | New Buy | 15,060 | $23.51 |
Renaissance Technologies (RenTech)'s Integra LifeSciences Holdings Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased Integra LifeSciences Holdings Corporation (IART) in Q2 2014, acquiring 15,060 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Integra LifeSciences Holdings Corporation (IART) for 40 quarters since Q2 2014.
Renaissance Technologies (RenTech)'s largest addition to Integra LifeSciences Holdings Corporation (IART) was in Q3 2018, adding 358,160 shares worth $23.59 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 14,760 shares of Integra LifeSciences Holdings Corporation (IART), valued at approximately $183,319.
As of the Q4 2025 filing, Integra LifeSciences Holdings Corporation (IART) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Integra LifeSciences Holdings Corporation (IART) was 405,800 shares, as reported at the end of Q4 2017.